Pure Global AI
NCT06381102Recruiting

Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1

How Does the Length of Pulse Trains and Pulse Intervals Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?
University of MiamiClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Healthy
Drug/Device/Intervention
transcutaneous auricular vagus nerve stimulation 30/30
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Miami
Location
Miami, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 13, 2024
End date
Oct 01, 2024
Enrollment
30 participants
Primary outcome

Tolerability measured by tolerability questionnaire,Tolerability measured by self-report

Summary

The purpose of this research study is to investigate the effects of different forms of a
 gentle form of electrical stimulation applied to the ear, known as transcutaneous auricular
 vagus nerve stimulation (taVNS). The research team is interested in how the different forms
 affect comfort and tolerability, as well as how well it works.

ICD-10 classifications
ObesitySeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulHealthy person accompanying sick personLifestyle-related conditionMalnutrition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381102
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06381102 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Recruiting. The study focuses on Healthy. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.